From Silent Epidemic to Measurable Value

Rethinking Alzheimer’s Through a Health Systems Lens 17.11.25

Our latest article reframes Alzheimer’s disease (AD) as a health system risk multiplier, exploring the knock-on effects of the disease and its management on global health systems. Louise Hogg, our Market Access director, explores:

  • Cost structures: elevated healthcare costs related to heightened risks of health issues outside of disease management
  • Diagnostic pathways: inequitable diagnosis, treatment, and support structures
  • Workforce needs: short supply of neurologists and geriatricians in many regions 

Download and read the paper to discover Ipsos’ commentary on the real-world evidence (RWE) and health economics and outcomes research (HEOR) opportunities in the Alzheimer’s disease space.

Download

Related news

  • [Webinar] KEYS: Battle For Attention
    Communication Events replay

    [Webinar] KEYS: Battle For Attention

    In an era dominated by ad-skipping, multi-screening, and media fragmentation, the challenge for today’s marketer is no longer just “Who am I reaching?” but “Am I reaching them at all?"
  • Where is metabolic medicine heading
    Healthcare Events replay

    Where is metabolic medicine heading – and what do you need to know?

    What happens when pipeline promise becomes market reality? During this PBSS webinar, Scott Morano and Roberto Cortese expertly guide viewers through the recent transformations in metabolic therapeutics for obesity, diabetes and MASH, and where the field is heading next.
  • KEYS: Screen time
    Media Measurement Events replay

    [WEBINAR] KEYS: Screen time

    At our first KEYS webinar of the year we’ll be looking at what’s really happening on screens these days. What’s changing? What’s enduring? And how can businesses do better when it comes to engaging with people on their screens, in real time?